home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

186 rows where filing_period = "third_quarter", filing_year = 2010 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 186 ✖

filing_year 1

  • 2010 · 186 ✖

filing_period 1

  • third_quarter · 186 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
987236 LONG TERM CARE PHARMACY ALLIANCE 85fc0951-af88-415c-beaa-af7d171459cc Q3 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2010 third_quarter PHA Medicare Part D in Long Term Care Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   210000 0 0 2010-09-30T11:17:51.037000-04:00
987612 MEREDITH MCGEHEE 74dc0729-e70b-45af-b502-1ab7d013f9fc Q3 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2010 third_quarter PHA Funding for programs to develop AIDS vaccines targeted toward the developing world; Working Global Health Technologies to educate on research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR Appropriations for USAID R&D and funding for IAVI; Providing information on IAVI's Antibody Project and PDP model; Providing input on foreign assistance reform from a global health perspective HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-04T12:14:36.837000-04:00
987927 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2330c816-9c47-495a-bd8f-a641c3cc7bae Q3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2010 third_quarter PHA Communications with Food and Drug Admnistration on Risk Evaluation and Mitigation Strategies, reauthorization of the Prescription Drug User Fee Act, medical product recalls, experimental study of patient information prototypes and patient medication information, drug shortages, and generic drug user fees. Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. HR 5389, The Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010, all provisions. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2010-10-05T15:34:29.837000-04:00
988241 THE OB-C GROUP, LLC 8b0074fe-ecb9-494b-bcd0-04372dd21a2e Q3 THE OB-C GROUP, LLC 29802 ELI LILLY 2010 third_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-06T13:37:05.427000-04:00
988357 AMERICAN COLLEGE OF CLINICAL PHARMACY 6b3d7b2e-ef32-422c-9000-3dbb7f714c43 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2010 third_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   64750 0 0 2010-10-06T15:52:22.300000-04:00
989075 GILBERT'S LLP cb0c4d0e-225e-4051-85db-9ea57a3916cf Q3 GILBERT'S LLP 67876 MYLAN LABORATORIES INC 2010 third_quarter PHA Reform to legislation and regulations affecting pharmaceutical drug approval and marketing   105000   0 0 2010-10-08T13:58:58.820000-04:00
989578 CYBER SECURITY RESEARCH CONSULTANTS, LLC 4d857f80-8a16-4c50-8a7e-a8ec27ae407f Q3 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2010 third_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Health Care Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-10-11T11:09:57.993000-04:00
989707 LOCKE LORD PUBLIC POLICY GROUP LLC 1b8f8e4e-d27b-47f7-888c-bae6da9aadb0 Q3 LOCKE LORD PUBLIC POLICY GROUP LLC 300971 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2010 third_quarter PHA Pharmaceutical performance reimbursement; biogenics HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-11T15:24:51.677000-04:00
989742 INDEPENDENT PHARMACY COOPERATIVE 6a344eb2-b00c-4278-bbc1-4f0c241bb325 Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2010 third_quarter PHA Average Manufacturer Price Pharmacy Reimbursement H.R. 3590 agency implementation DEA Physician/Agent Definition in Skilled Nursing Facilities PBM Transparency in Health Insurance "Exchanges" H.R. 3590 H.R. 3790 Repeals DMEPOS Competitive Bidding Medicare Centers For Medicare & Medicaid Services: Concerns with short-cycle dispensing in long-term care facilties. IRS:Concerns with 1099 reporting provisions in PL 111-148. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE   10000 0 0 2010-10-11T16:30:04.587000-04:00
989758 UNIVERSITY OF IOWA 0027a4bd-0fc4-42b2-a23c-9fc2a28de7d2 Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2010 third_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   110000 0 0 2010-10-11T16:35:15.390000-04:00
989958 HOLLAND & KNIGHT LLP d64263d2-40b8-4bf5-a436-c598d5cd8bd0 Q3 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2010 third_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2010-10-12T10:25:16.497000-04:00
989988 HOLLAND & KNIGHT LLP 4473a560-f06b-46ac-80f3-9ebbf50ab45c Q3 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2010 third_quarter PHA Blood and blood product safety; issues related to blood product approvals; Blood donor deferral policies, 340B Drug purchasing program and orphan drugs. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2010-10-12T10:34:19.177000-04:00
990140 PARRY, ROMANI, DECONCINI & SYMMS 56e75c33-746d-462c-87ff-c2c21f6a86a0 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2010 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-10-12T12:14:54.020000-04:00
990229 PARRY, ROMANI, DECONCINI & SYMMS 83989e62-b43b-4a56-8c5b-62ba25464aa0 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2010 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-10-12T12:53:15.847000-04:00
990240 PARRY, ROMANI, DECONCINI & SYMMS 2e4009f0-23b1-4989-b9a4-a5bd119f9e41 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2010 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-10-12T13:07:17.187000-04:00
990268 PARRY, ROMANI, DECONCINI & SYMMS c9b098b0-6c17-4099-b847-c39c4f5ad0c7 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2010 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-10-12T13:18:30.287000-04:00
990344 PARRY, ROMANI, DECONCINI & SYMMS 1ab2ac1e-a09b-48b5-a273-c4d171d0bae9 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2010 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2010-10-12T14:13:03.877000-04:00
990749 RUBICON ADVISORS, LLC b74f7f1f-8c73-4e56-9ccd-a03761c77c53 Q3 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2010 third_quarter PHA Physiciam Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act   30000   0 0 2010-10-12T22:58:03.633000-04:00
990750 RUBICON ADVISORS, LLC 4e1ef1ff-f87d-48a2-83ca-7bf44abbd762 Q3 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2010 third_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2010-10-12T23:03:04.543000-04:00
990751 RUBICON ADVISORS, LLC 764fb4cb-b125-4270-937a-eae38aeab584 Q3 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2010 third_quarter PHA Generic Biologics S. 1695 Affordable Health Care Choices Act   22500   0 0 2010-10-12T23:08:05.453000-04:00
990752 RUBICON ADVISORS, LLC d1f368c9-b4a8-47a7-8743-09c9ded1e2c0 Q3 RUBICON ADVISORS, LLC 315091 OSMOTICA PHARMACEUTICALS 2010 third_quarter PHA FDA Citizen Petition Reform Affordable Healthcare Choices Act   35000   0 0 2010-10-12T23:15:06.383000-04:00
990753 RUBICON ADVISORS, LLC b3c0dda7-17fa-47a6-927d-bb15b4a08337 Q3 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2010 third_quarter PHA Patent Settlements H.R. 1432, Genetic Biologics S. H.R. 1695, H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affordable Health Choices Act   105000   0 0 2010-10-12T23:19:07.290000-04:00
990754 RUBICON ADVISORS, LLC a918e9af-a8f0-4324-9919-93625bcb127e Q3 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2010 third_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S. 316 Generic Biologics S. 1685 H.R. 5629 Physician Payment Sunshine Act S. 2029   98000   0 0 2010-10-12T23:23:08.217000-04:00
991258 RANDOLPH E. CLOUD & ASSOCIATES 494026f5-5cb6-4166-b267-2d50522616ff Q3 RANDOLPH E. CLOUD & ASSOCIATES 400451152 PHRMA(ON BEHALF OF WE WORK FOR HEALTH) 2010 third_quarter PHA Issues dealing with pharmaceutical innovation, patent protection, and Medicaid reimbursement duringly being implemented or discussed in Congress PhRMA Members found here: http://www.phrma.org/about_phrma/member_company_list/members HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-10-13T12:56:20.037000-04:00
991542 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM b08c1dde-f2c8-4181-be30-955f3e6dd2fb Q3 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2010 third_quarter PHA S3686 Support language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers, by expanding 340 B drug discounts to inpatient settings. HOUSE OF REPRESENTATIVES,SENATE   80530 0 0 2010-10-13T14:48:26.493000-04:00
991580 NAHIGIAN STRATEGIES, LLC 2aff2717-5515-443d-9850-78604c031d9e Q3 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2010 third_quarter PHA Generic pharmaceuticals issues. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-10-13T15:00:37.110000-04:00
991646 OMNICARE, INC. f04527c4-55d2-45be-9dd6-8e8e171982aa Q3 OMNICARE, INC. 321112 OMNICARE INC 2010 third_quarter PHA DEA policies regarding dispensing of controlled substances to residents of long-term care facilities. HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2010-10-13T15:30:13.377000-04:00
992361 DUTKO WORLDWIDE, LLC 3faece46-88d3-48d8-86df-2d1aa9b583dd Q3 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2010 third_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-14T10:43:04.687000-04:00
992937 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) b59f2833-d6f7-4bb1-a9bb-5cc425f4e0cc Q3 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2010 third_quarter PHA Importation of prescription drugs (S. 525/H.R. 1298); House Energy and Commerce Committee discussion draft; Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   270000 0 0 2010-10-14T13:30:16.567000-04:00
993886 CAPITOL HILL CONSULTING GROUP 606afef9-7e70-412a-aea8-361d68a47b84 Q3 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2010 third_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-14T18:45:57.673000-04:00
993936 WINBORN SOLUTIONS LLC 61e4d787-7b44-4787-afbd-18f617b2d948 Q3 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2010 third_quarter PHA Dextromethorphan Distribution Act of 2009 Legislation to regulate the sale of pseudoephedrine Food and drug safety, user fee, and country of origin legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2010-10-14T20:18:23.780000-04:00
994240 AMERICAN ADVERTISING FEDERATION a1a2ecdb-fce0-4862-aec6-2020cfdd7d11 Q3 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2010 third_quarter PHA health care reform legislation as it affects the taxation or content of pharmaceutical advertising HR 2175, to prohibit as indecent the broadcasting of any advertisement for a medication for the treatment of erectile dysfunction Proposals to require a moratorium on the advertising of new prescription medications Proposals to extend Food and Drug Administration authority for over-the-counter medications Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2010-10-15T11:21:00.357000-04:00
994296 INDEPENDENCE BLUE CROSS acdeee71-475f-4457-a9be-e449b74905e4 Q3 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2010 third_quarter PHA comparative effectiveness, medication safety pharmacy antitrust issues?? Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office     0 0 2010-10-15T11:37:39.353000-04:00
994539 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION c41c4e14-4dda-4666-8c73-7f37218e9c9c Q3 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2010 third_quarter PHA H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out" laws on generic utilization. H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act. H.R. 5234 - PBM Audit Reform and Transparency Act H.R. 4872 - Health Care and Education and Reconciliation Act of 2010 H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Election Commission (FEC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   644765 0 0 2010-10-15T13:00:00.737000-04:00
996244 BLUE CROSS BLUE SHIELD OF MICHIGAN fcc46331-4891-455e-8011-34569890b5d1 Q3 BLUE CROSS BLUE SHIELD OF MICHIGAN 46676 BLUE CROSS BLUE SHIELD OF MICHIGAN 2010 third_quarter PHA Comparative Effectiveness Pharmacy Anti-Trust HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2010-10-18T09:08:24.870000-04:00
996590 UNIVERSITY OF CONNECTICUT 3650c7a9-a845-4ff5-84b9-0263264781b2 Q3 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2010 third_quarter PHA S.3606, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)   70000 0 0 2010-10-18T10:35:13.793000-04:00
996620 POLICY DIRECTIONS INC. c7a4333b-affa-4725-8203-7b7a2424ad20 Q3 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2010 third_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-18T10:38:22.403000-04:00
997045 BROWN RUDNICK LLP e1717dc3-9c22-4305-9b8c-37bfb7792e44 Q3 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2010 third_quarter PHA S.525 & S.1298- Pharmaceutical Market Access and Drug Safety Act of 2009; Drug Pedigree House Energy and Commerce Committee Drug Import Safety Discussion Draft HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-10-18T11:31:50.090000-04:00
997130 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION d68e62e4-8eb4-4677-b248-cabe4f388e27 Q3 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2010 third_quarter PHA H.R. 1204, the Community Pharmacy Fairness Act of 2009; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; worked with the Senate Committee on Aging to provide information for an ongoing committee investigation of certain retail pharmacy practices; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; submitted statement for the House Committee on Energy and Commerce hearing on the Part B DME competitive bidding program; H.R. 1586, the Education Jobs and Medicaid funding bill, which included an extension of FMAP and change to the AMP definition and became law on 8/10/2010; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act, includes funding for the Department of Defense and covers the TRICARE pharmacy program; H.R. 3108 and S. 1383, the Medication Therapy Management (MTM) Expanded Benefit Act; worked with Senate offices to gain support for the implemenation of an authpirzed grant program for MTM services; worked with Senate Aging Committee on the issue of nurses as agents in long-term care facilties; H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 (NASPER); H.R. 5809, the Safe Drug Disposal Act and S. 3397, the Secure & Responsible Drug Disposal Act (became law 10-12-10); worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sough Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices in seeking clarification fro… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,Small Business Administration (SBA),Treasury, Dept of   130000 0 0 2010-10-18T11:43:38.637000-04:00
997141 MEHLMAN CONSULTING, INC. 299a11b0-4a6e-4077-988d-7544ee873734 Q3 MEHLMAN CONSULTING, INC. 284950 ABBOTT LABORATORIES 2010 third_quarter PHA Drug pricing, FDA reforms, Reimbursement. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-10-18T11:46:46.107000-04:00
997768 ELI LILLY AND COMPANY c26fed67-88cc-4ac4-8ea2-36a4f281bd4d Q3 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2010 third_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   2135000 0 0 2010-10-18T13:51:10.507000-04:00
997971 GREATER NEW YORK HOSPITAL ASSOCIATION 3eabaea5-c76a-4fff-b13a-70a59e1e2e76 Q3 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2010 third_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590, P.L. 111-148; H.R.4872, P.L. 111-152); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239); H.R.4213) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   300000 0 0 2010-10-18T14:24:23.280000-04:00
998051 JULIE PHILP 7f177fcc-406b-4eb9-801f-f21b37cf4bfa Q3 JULIE PHILP 400407928 NATIONAL GRASSROOTS AND COMMUNICATION 2010 third_quarter PHA Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund to pay for prescription medicines for low-income indidviduals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-18T14:37:44.030000-04:00
998174 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 7362913f-3934-4fec-abef-98c71840e89f Q3 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 309377 ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 2010 third_quarter PHA Support legislation (HR4199) to define pharmacists as health care professionals under Medicare; increase dispensing fees for pharmacies; elimiate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals. HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-10-18T14:49:15.043000-04:00
998302 FAEGRE BAKER DANIELS CONSULTING 1ce73ca7-00cc-46e1-900d-3abaa477a94b Q3 FAEGRE BAKER DANIELS CONSULTING 34158 ELI LILLY 2010 third_quarter PHA issue is on-line pharmacies Executive Office of the President (EOP),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 8000   0 0 2010-10-18T15:03:54.257000-04:00
998534 SMITH GARSON FKA SMITH DAWSON & ANDREWS 334dc5c6-2d66-459b-a472-dcd7fd08d97f Q3 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 PROSETTA CORPORATION 2010 third_quarter PHA Government Advertisement of Biopharmaceuticals SENATE 7500   0 0 2010-10-18T15:34:52.743000-04:00
998584 SMITH GARSON FKA SMITH DAWSON & ANDREWS 57f3b73d-618f-4443-9edc-14fb0ee2280d Q3 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 STRUVE SWINE TECHNOLOGIES 2010 third_quarter PHA Government Advertisement of Biopharmaceuticals SENATE 7500   0 0 2010-10-18T15:42:13.117000-04:00
998641 VENABLE LLP 90414ef6-33b2-4e52-8631-fb9607da8849 Q3 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2010 third_quarter PHA General issues affecting the pharmaceutical industry HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-10-18T15:47:49.530000-04:00
998657 PD FRAZER CONSULTING, INC. ad32ce91-6c3a-4edc-8b5d-10c756776692 Q3 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2010 third_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-18T15:51:47.773000-04:00
998792 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 3a599f70-348c-466b-9f97-d053195dde95 Q3 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2010 third_quarter PHA Proposals to place a moratorium on prescription drug advertising and requiring a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to extend FDA authority to over-the-counter drug advertisements FDA notice of proposed rulemaking to implement requirements for "major statement" in DTC television or radio ads H.R. 2175 - Families for ED Decency Act, to prohibit the broadcast of drugs for erectile dysfuncton/male enhancement on indecency grounds Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   270000 0 0 2010-10-18T16:12:47.373000-04:00
998877 SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES b33de76b-8c88-497f-b66d-e31fcc139495 Q3 SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES 37538 SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES 2010 third_quarter PHA HR 4816, the Food and Drug Administration Improvement Act of 2010, provisions related to providing the Food and Drug Administration with resources to ensure safety of drugs imported into the US from foreign countries. S. 3690 Drug Safety and Accountability Act of 2010, provisions related to provising the Food and Drug Administration with adequate resources to ensure safety of drugs imported to the US from foreign manufacturers. HOUSE OF REPRESENTATIVES,SENATE   79000 0 0 2010-10-18T16:25:16.090000-04:00
999533 PODESTA GROUP, INC. 0509b863-295e-4f1b-9a8a-386e9fa02063 Q3 PODESTA GROUP, INC. 31680 COVIDIEN 2010 third_quarter PHA Issues involving controlled substances and pain and addiction drugs generally Issues related to acetaminophen Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 50000   0 0 2010-10-18T18:47:22.793000-04:00
999555 PODESTA GROUP, INC. 4bb57868-9464-4507-bcfa-0be31f2bd8a9 Q3 PODESTA GROUP, INC. 31680 MILLENNIUM PHARMACEUTICALS INC 2010 third_quarter PHA Drug Safety/Pedigree Bills P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-10-18T18:52:36.060000-04:00
1001052 AMYLIN PHARMACEUTICALS d68a9ba6-3c70-48cc-aadd-022a3d3ac542 Q3 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2010 third_quarter PHA Drug importation issues HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2010-10-19T10:22:49.397000-04:00
1001433 TARPLIN, DOWNS & YOUNG, LLC 65da2f63-b859-4ce3-b900-e77bcb08476a Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2010 third_quarter PHA **see addendum page **, no specific bill(s), Prescription Drug Importation, Import Safety Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-10-19T10:58:05.333000-04:00
1001508 GREENBERG TRAURIG, LLP 39df83fc-3332-4d1a-b1e4-cd52f22a4d68 Q3 GREENBERG TRAURIG, LLP 16896 RICHIE & GUERINGER, P.C. 2010 third_quarter PHA Congressional actions on health care reform. HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-10-19T11:01:28.833000-04:00
1001891 KENT & O'CONNOR, INC. a3cc888c-d903-497d-86d6-72c4f9dd0efe Q3 KENT & O'CONNOR, INC. 21426 INTERNATIONAL WAREHOUSE LOGISTICS ASSOCIATION 2010 third_quarter PHA Legislation and regulations relating to drug safety issues Consumer Product Safety Commission (CPSC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),SENATE,Surface Transportation Board (STB),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection 20000   0 0 2010-10-19T11:24:16.643000-04:00
1001919 OGR 1eaa3364-5b4d-4347-9dc2-05a94414ebbb Q3 OGR 48827 SANOFI PASTEUR 2010 third_quarter PHA vaccine related issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-10-19T11:26:28.847000-04:00
1002056 VAN HEUVELEN STRATEGIES, LLC 988ef3fe-d500-422e-bcdd-795bd8bc184c Q3 VAN HEUVELEN STRATEGIES, LLC 321874 DAVITA 2010 third_quarter PHA H.R. 1, American Recovery and Reinvestment Act of 2009; Provisions pertaining to kidney care, dialysis, Medicare, CMS reimbursement issues,and health insurance; S.Con.Res. 13 - FY 2010 Budget; S. 1679, The Affordable Health Choices Act; H.R. 3200, America's Affordable Health Choices Act of 2009; S. 1796, America's Healthy Future Act; S. 1776, Medicare Physician Fairness Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-19T11:34:58.413000-04:00
1002154 THE CHILDREN'S HOSPITAL OF PHILADELPHIA 89648d3f-ff6f-4ae9-9a45-3d11e6325da2 Q3 THE CHILDREN'S HOSPITAL OF PHILADELPHIA 9077 THE CHILDREN'S HOSPITAL OF PHILADELPHIA 2010 third_quarter PHA H.R. 4213, the "American Workers, State and Business Relief Act of 2010," Title V, Subtitle B, Section 517 relation to the inclusion of ophan drugs under the 340B drug discount program for eligbile children's hospitals Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   45000 0 0 2010-10-19T11:46:01.987000-04:00
1002324 AMERICAN VETERINARY MEDICAL ASSOCIATION 61481c99-f153-483e-bec7-967ba17dabd7 Q3 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2010 third_quarter PHA H.R. 1549/S. 619, Preservation of Antibiotics for Medical Treatment Act H.R. 2400, Strategies to Address Antimicrobial Resistance (STAAR) Act Potential veterinary prescription writing legislation Agriculture, Dept of (USDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2010-10-19T11:59:05.380000-04:00
1002354 R AND J GROUP, INC. fe183bcc-7d78-4de4-a661-bbe6932d39a7 Q3 R AND J GROUP, INC. 400483384 SUNOVIAN PHARMACEUTICALS INC (F/K/A SEPRACOR INC ) 2010 third_quarter PHA Legislation affecting the pharmaceutical industry; healthcare reform bill. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-19T12:02:04.517000-04:00
1002460 TARPLIN, DOWNS & YOUNG, LLC 257d611e-204f-4370-9aad-37d87f35538f Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2010 third_quarter PHA **see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923)) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710) Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-10-19T12:09:46.490000-04:00
1002573 340B HEALTH 3aebde46-0d8e-403f-a78b-455ee2eb8f7c Q3 340B HEALTH 316434 340B HEALTH 2010 third_quarter PHA S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   241325 0 0 2010-10-19T12:17:16.953000-04:00
1003093 EXPRESS SCRIPTS, INC. 48b07e60-b190-4d29-9daf-c3cbce9cfb97 Q3 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2010 third_quarter PHA Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   430000 0 0 2010-10-19T13:00:12.460000-04:00
1003103 FLYNN & ASSOCIATES, INC. e93c0fb1-28bf-4700-9d27-60ca1af08d36 Q3 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2010 third_quarter PHA Pharmaceutical Industry Employment Issues HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-10-19T13:04:15.460000-04:00
1004087 EISAI INC. cefdcb28-ac02-43a7-9dd7-6f4de41d9009 Q3 EISAI INC. 400321512 EISAI INC. 2010 third_quarter PHA biosimilars, follow-on biologics Biologics Price Competition and Innovation Act of 2009 P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 health Care and Education Reconciliation Act of 2010 Education, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   800000 0 0 2010-10-19T14:30:12.943000-04:00
1004165 HANCE SCARBOROUGH b73c0427-f154-4ff2-9034-a2d1b5da009b Q3 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2010 third_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-10-19T14:34:13.267000-04:00
1004434 HANCE SCARBOROUGH 4600bcca-e49b-4132-9855-dec2f393bedb Q3 HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2010 third_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-10-19T14:49:53.877000-04:00
1004437 MCDERMOTT WILL & SCHULTE LLP d2809579-c79b-4de6-9701-3939eb51f7aa Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2010 third_quarter PHA Issues related to Section 340B of the Public Health Service Act. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-10-19T14:49:55.877000-04:00
1004604 AMERICAN PHARMACISTS ASSOCIATION f1a4e68d-f766-4df9-adac-38402db65ee4 Q3 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2010 third_quarter PHA HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies DEA National Drug Take-Back Day Concept Standardizing REMS programs, components and development of a… Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   212859 0 0 2010-10-19T14:57:56.533000-04:00
1005039 AKIN GUMP STRAUSS HAUER & FELD 00ce4b06-be71-45b2-8f7f-07e1934e0de3 Q3 AKIN GUMP STRAUSS HAUER & FELD 682 PRASCO, INC. 2010 third_quarter PHA Promoting consumer benefits of authorized generic drugs Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-19T15:20:37.177000-04:00
1005062 ASSOCIATION FOR ACCESSIBLE MEDICINES f52e54a3-d453-4673-86bb-47cb6e3d658f Q3 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2010 third_quarter PHA Budget Reconcilliation, Implementation of Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" H.R.4213 - American Jobs and Closing Tax Loopholes Act H.R.4899 - War Supplemental S.1315 - Drug Price Competition Act of 2009 Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office   372750 0 0 2010-10-19T15:21:45.410000-04:00
1005446 AMERICAN HEALTH CARE ASSOCIATION 16c45f45-01ba-4098-9e37-7ee3a315cd00 Q3 AMERICAN HEALTH CARE ASSOCIATION 2491 AMERICAN HEALTH CARE ASSOCIATION 2010 third_quarter PHA Updating controlled sustances regulations for long-term care. S.3397: Secure and Responsible Drug Disposal Act of 2010. H.R.5809: The Safe Drug Disposal Act of 2010. Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),SENATE   500000 0 0 2010-10-19T15:41:21.427000-04:00
1005522 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 52fd765b-208e-4684-818b-c9b042d1a4c7 Q3 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2010 third_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-10-19T15:45:10.287000-04:00
1005767 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) c9553b01-64fd-4259-a6d2-5628e4fb32fd Q3 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 THE PEW CHARITABLE TRUSTS 2010 third_quarter PHA Issues pertaining to pharmaceutical supply chain and drug safety. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-10-19T15:56:27.677000-04:00
1005849 INTEGRATED SOLUTIONS GROUP 0d35179f-f1d3-4135-8c8a-e60ad6883ffc Q3 INTEGRATED SOLUTIONS GROUP 317275 TEVA PHARMACEUTICALS USA 2010 third_quarter PHA H.R. 1432 - Patent Settlements; H.R. 1695 - Generic Biologics; H.R. 5629 - Physician Payment Sunshine Act; S.2029 - Patent Reform; H.R. 1908 - Import Safety Act; H.R. 3100 - Affordable Health Choices Act S.515 - Patent Reform Act Financial services and general appropriations bill - 2010 Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-10-19T16:02:24.927000-04:00
1005888 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 15056c92-ba6e-4582-bef6-d4390fa19c2d Q3 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2010 third_quarter PHA H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market ccess Act of 2009. S.511, Access to Durable Medical Equipment Act S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   400000 0 0 2010-10-19T16:06:18.757000-04:00
1006089 MCDERMOTT WILL & SCHULTE LLP 2d37b22e-7b17-4ecf-b43b-83ef123bc9bf Q3 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2010 third_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2010-10-19T16:17:04.690000-04:00
1006175 BUCHANAN INGERSOLL & ROONEY PC 694335b4-a335-419d-b663-4efd5aa70f27 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2010 third_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-10-19T16:21:27.690000-04:00
1006426 TARPLIN, DOWNS & YOUNG, LLC e46b3d41-9a2d-450d-b1e9-21ffc215f0cf Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2010 third_quarter PHA **see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2010-10-19T16:38:59.980000-04:00
1006668 TARPLIN STRATEGIES LLC 32c4b0db-9069-4656-936f-1a1ee2e82a8b Q3 TARPLIN STRATEGIES LLC 40032282 GENENTECH, INC. 2010 third_quarter PHA Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare prescription drug benefit. H.R. 4213, the American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes related to the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2010-10-19T16:54:17.637000-04:00
1006673 TARPLIN, DOWNS & YOUNG, LLC c3f2e2af-7c53-4c7f-bfcc-4ce3caed019c Q3 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2010 third_quarter PHA **see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), prescription drug importation, import safety HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-10-19T16:54:20.137000-04:00
1006860 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC e902bf11-02a1-48d4-a600-9b8bbcce8f25 Q3 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 41113 JARROW FORMULAS, INC. 2010 third_quarter PHA Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius; S. 510 and the Dietary Supplement Health and Education Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-19T17:10:41.127000-04:00
1006972 MCDERMOTT WILL & SCHULTE LLP da708c83-e61e-43d9-b2de-ccb53eee25d4 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2010 third_quarter PHA Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2010-10-19T17:23:25.097000-04:00
1007086 KAISER FOUNDATION HEALTH PLAN INC. 00247839-36cc-4722-ae60-7b947abe9afd Q3 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2010 third_quarter PHA S 726 Promoting Innovation and Access to Life-Saving Medicine Act To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products. Sponsor: Schumer (D-NY) Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   180000 0 0 2010-10-19T17:31:02.267000-04:00
1007276 FABIANI & COMPANY 05d32b39-baf7-4c9b-98ac-b402beed57c0 3T FABIANI & COMPANY 72576 AFRAXIS 2010 third_quarter PHA Securing federal R&D for treatment of central nervous system diseases Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE     0 1 2010-10-19T17:45:36.650000-04:00
1007383 PODESTA GROUP, INC. 863b844b-3f5d-4452-9c2d-1f77d0c90a34 Q3 PODESTA GROUP, INC. 31680 NOVO NORDISK INC 2010 third_quarter PHA Drug Importation, Biosimilars P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 S. 3607 Department of Homeland Security Appropriations Act, 2011 (Drug Importation) S. 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011 (FDA Appropriations, Drug Importation) S. 3636 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011 (PTO Provisions, Drug Importation) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions) S. 3397 Secure and Responsible Drug Disposal Act of 2010 H.R. 1359 Secure and Responsible Drug Disposal Act of 2009 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2010-10-19T17:52:04.760000-04:00
1007464 BUCHANAN INGERSOLL & ROONEY PC 715a2341-ee97-4f4b-8721-b1a0c6676289 Q3 BUCHANAN INGERSOLL & ROONEY PC 55291 PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO 2010 third_quarter PHA Patent reform, drug importation HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-10-19T18:00:47.690000-04:00
1007681 WINNING STRATEGIES WASHINGTON bdca7db6-75e4-45ea-9d86-0f4876ca9c73 Q3 WINNING STRATEGIES WASHINGTON 50796 MEDA PHARMACEUTICALS 2010 third_quarter PHA FDA Risk Evaluation and Mitigation Strategies HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-10-19T18:26:29.353000-04:00
1007692 WINSTON & STRAWN LLP 31b03ed6-ff6d-49c3-8871-ef8e512a4ed1 Q3 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2010 third_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters, including settlements. Legislation of interest includes the FY 2011 Financial Services Appropriations Bill (S. 3677), the FY 2010 Supplemental Appropriations Bill (H.R. 4899; P.L. 111-212), and the Preserve Access to Affordable Generics Act (S. 369). HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-10-19T18:27:45.003000-04:00
1007746 PODESTA GROUP, INC. 56276514-8335-4a4e-ae05-ab520eeaddc6 Q3 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2010 third_quarter PHA Drug Importation/Drug Safety P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-10-19T18:37:52.540000-04:00
1008440 ANIMAL HEALTH INSTITUTE 35e7ceb6-eb08-475c-89f0-1f0177460f4f Q3 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2010 third_quarter PHA Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009; S3307, Healthy Hunger Free Kids Act of 2010; Improving Nutrition for America's Children Act.; Improvement of regulatory review processes for animal health products at FDA Center for Veterinary Medicine and USDA Center for Veternary Biologics HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2010-10-19T21:24:31.597000-04:00
1008656 MENTAL HEALTH AMERICA 24408a7c-1f88-4c71-ae14-1816dd0491b4 Q3 MENTAL HEALTH AMERICA 28195 MENTAL HEALTH AMERICA 2010 third_quarter PHA Regarding coverage of medications for mental health and substance use disorders in health care reform law (ACA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   12514 0 0 2010-10-20T01:28:18.940000-04:00
1008817 VAN SCOYOC ASSOCIATES eea74c0e-95c4-4351-9d8e-45029aaf30c7 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2010 third_quarter PHA S.3606, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) 40000   0 0 2010-10-20T05:32:35.327000-04:00
1008820 VAN SCOYOC ASSOCIATES c0d94e64-7a6f-4af6-b993-e786f2d2b774 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2010 third_quarter PHA No lobbying activity. Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-20T05:33:38.247000-04:00
1008833 VAN SCOYOC ASSOCIATES df76bc18-b26a-4ec8-918a-3aef21505f55 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2010 third_quarter PHA S.3606, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA and USDA funding initiatives; Critical Path Partnership. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-10-20T05:34:40.387000-04:00
1009160 CHAMBER OF COMMERCE OF THE U.S.A. 00122c03-9297-4f3f-bfdd-e47b8c5bf440 Q3 CHAMBER OF COMMERCE OF THE U.S.A. 38756 CHAMBER OF COMMERCE OF THE U.S.A. 2010 third_quarter PHA H.R. 1346 / S. 540, Medical Device Safety Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act (P.L. 111-148) Agriculture, Dept of (USDA),Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Council on Environmental Quality (CEQ),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Export-Import Bank of the United States (EXIM Bank),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Justice, Dept of (DOJ),Labor, Dept of (DOL),Maritime Administration (MARAD),Natl Aeronautics & Space Administration (NASA),Natl Economic Council (NEC),Natl Highway Traffic Safety Administration (NHTSA),Natl Institute of Standards & Technology (NIST),Natl Labor Relations Board (NLRB),Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),St. Lawrence Seaway Development Corporation,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   29250000 0 0 2010-10-20T08:02:31.560000-04:00
1009744 EVERTZ GROUP LLC 60d2fb43-d934-4a74-98a6-36a81555dff5 Q3 EVERTZ GROUP LLC 400497446 MYLAN INC. 2010 third_quarter PHA Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 30000   0 0 2010-10-20T09:41:05.057000-04:00
1010485 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 75057213-3a74-4564-b9b7-26210b69702a Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 NOVO NORDISK 2010 third_quarter PHA H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal exemption. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-10-20T10:33:33.337000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2337.862ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API